Newsfeeds Archive - Spark Newswire

3 minute read

Apollomics, A Company Developing Novel Oncology Therapies To Address Difficult-To-Treat Cancers, Announces Closing Of Business Combination And Listing On Nasdaq

March 30, 8:14 AM

Apollomics Inc. ("Apollomics" or the "Company"), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and

APLM

3 minute read

Reported Late Wednesday March 29, Apollomics Announces Completion Of Business Combination With Maxpro Capital Acquisition Corp. And Listing On Nasdaq; Expected To Commence Trading On March 30, 2023, On The Nasdaq Capital Market Under The Symbols “APLM”

By Happy Mohamed

March 30, 1:37 AM

Apollomics' Class A ordinary shares and public warrants are expected to begin trading today on the Nasdaq Capital Market under the ticker symbols 'APLM' and 'APLMW' FOSTER CITY, Calif., Mar 30, 2023

JMAC

2 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

By Chris Katje

March 23, 4:50 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks when it comes to spotting opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

AMD

3 minute read

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

March 17, 12:49 PM

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.

ACER

1 minute read

News

Maxpro Capital Acquisition Confirms Additional Funding, Extension Of Deadline To Complete Initial Business Combination

By Michael Horton

January 13, 5:14 PM

-Reuters

JMAC

1 minute read

News

Maxpro Capital Acquisition Corp. Announces Extension To Deadline To Complete Business Combination

By Benzinga Newsdesk

January 10, 5:07 PM

Maxpro Capital Acquisition Corp. (NASDAQ:JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the “Sponsor”), has requested that the Company extend the date by which the

JMAC

1 minute read

Apollomics To be Listed on Nasdaq Through Business Combination With Maxpro Capital Acquisition Corp.; Transaction Values Apollomics At Pre-Money Equity Value Of $899M

By Benzinga Newsdesk

September 14, 8:33 AM

Apollomics Inc. ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company, and Maxpro Capital Acquisition Corp. ("Maxpro") (NASDAQ:JMAC, , JMACU, , JMACW))))

JMAC